CAL-101 (Calluna Pharma)

N/A

Report date: 2025/07/22 20:00:10

Base Information

Drug NameCAL-101 (Calluna Pharma)
Drug Alias NameCAL-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProtein S100-A4 inhibitors
TargetsProtein S100-A4
Therapy Area/IndicationsInflammationFibrosisIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomaniaNetherlands +[10
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCalluna Pharma Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationFibrosisIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A